Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01655693 |
| Title | Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma (ReLive) |
| Acronym | ReLive |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Onxeo |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | TUR | LBN | ITA | HUN | FRA | ESP | DEU | BEL | AUT |